Welcome to Naked Stocks

Hey everyone,

Naked Stocks is back in action and better than ever! After some restructuring and major brainstorming on the future of the brand, the Naked Stocks team is ready to deliver the goods on all our favorite picks, and there are quite a few that we can’t wait to bare to all of you! While everyone else is caught up with words like recession, depression, crash and burn, we prefer to discuss growth, potential, bargains and steals.

We consider ourselves opportunists here at NS, and there are some wild things going on in the world of pharmaceutical companies right now that shows alot of promise. We’re going to do our best to keep you informed on all of the developments as they happen. The landscape is transforming in some big ways, rules are changing and paradigms are shifting! Check back everyday because today we start our first “Baring It All” series and its focus will be big Pharma. We’ll explore all of the ins-and-outs of the business, where it’s been and where it’s heading, and we’ll tell you which of the big players or small upstarts are ready and able to capitalize on the new challenges and opportunities that are opening up. This is gonna be good!

Sincerely,

Justin Picard

Editor of Naked Stocks